US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics Inc (EWTX) ニュース

EWTX

Edgewise Therapeutics (EWTX)

Edgewise Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EWTX

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/17	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/12/16	20 : 00	Business Wire	Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/12/06	04 : 32	Business Wire	Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/11/26	20 : 00	Business Wire	Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/11/07	22 : 53	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/11/07	22 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/11/07	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/11/07	22 : 00	Business Wire	Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/10/01	21 : 00	Business Wire	Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/25	09 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/25	09 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/21	05 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/21	05 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/19	20 : 00	Business Wire	Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/09/18	05 : 01	Business Wire	Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/15	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/15	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/13	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/08	21 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/08	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/08/08	21 : 00	Business Wire	Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/06/13	08 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/10	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/10	22 : 07	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/10	21 : 00	Business Wire	Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/09	22 : 21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/09	21 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/09	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/09	21 : 00	Business Wire	Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:EWTX	Edgewise Therapeutics Inc
2024/05/07	22 : 16	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EWTX	Edgewise Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:EWTX

1 2 3 4 5 6 7 8 次へ >>

Bank of America

Gold vs US Dollar

Verizon Communications

Health Care Select Sector

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約